非甾体抗炎药口服预给药对不可逆性牙髓炎下牙槽神经阻滞麻醉成功率的影响:系统评价与Meta分析及试验序贯分析
Meta分析显示,任何NSAID均显著提高IANB麻醉成功率(RR=1.92,95%CI 1.55-2.38),布洛芬>400 mg/d有效,而≤400 mg/d无关联。结论认为NSAIDs预给药可提高IANB麻醉成功率。
要点
- NSAIDs口服预给药可显著提高不可逆性牙髓炎患者IANB麻醉成功率。
- 布洛芬>400 mg/d有效,≤400 mg/d与麻醉成功率无显著关联。
- 双氯芬酸和酮咯酸也显示有益效果,但证据质量需结合具体临床判断。
核心结论
- 口服NSAIDs预给药可提高不可逆性牙髓炎患者下牙槽神经阻滞麻醉的成功率。
- 布洛芬剂量>400 mg/d时显示有效,≤400 mg/d时未显示显著关联。
研究设计与样本
- 系统评价与Meta分析及试验序贯分析,检索三个数据库至2017年9月。
- 采用随机效应模型计算风险比(RR)及95%置信区间(CI),并进行试验序贯分析和GRADE证据质量评价。
主要发现
- 任何NSAID与安慰剂相比,提高IANB麻醉成功率的RR=1.92(95%CI 1.55-2.38)。
- 布洛芬亚组RR=1.83(95%CI 1.43-2.35),双氯芬酸RR=2.56(95%CI 1.46-4.50),酮咯酸RR=2.07(95%CI 1.47-2.90)。
- 布洛芬>400 mg/d的RR=1.85(95%CI 1.39-2.45),≤400 mg/d的RR=1.78(95%CI 0.90-3.55)。
- 试验序贯分析确认NSAIDs预给药有益效果的证据为结论性。
关键数值与推荐
- GRADE评价未对结果质量提出担忧。
临床怎么用
- 对不可逆性牙髓炎行下颌牙IANB前,可考虑口服NSAIDs(如布洛芬>400 mg/d)作为预给药以提高麻醉成功率。
- 需结合患者禁忌症和具体药物选择个体化决策。
局限性
- 检索截止至2017年9月,未纳入此后发表的RCT。
- 不同NSAID种类和剂量的直接比较证据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Successful anesthesia with an inferior alveolar nerve block (IANB) is imperative for treating patients with irreversible pulpitis in mandibular teeth. This systematic review assessed the efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) as oral premedications on the success of IANBs in irreversible pulpitis. METHODS: Three databases were searched to identify randomized clinical trials (RCTs) published up until September 2017. Retrieved RCTs were evaluated using the revised Cochrane Risk of Bias Tool. The primary efficacy outcome of interest was the success rate of IANB anesthesia. Meta-analytic estimates (risk ratio [RR] with 95% confidence intervals [CIs]) performed using a random effects model and publication bias determined using funnel plot analysis were assessed. Random errors were evaluated with trial sequential analyses, and the quality of evidence was appraised using a Grading of Recommendations, Assessment, Development and Evaluation approach. RESULTS: Thirteen RCTs (N = 1034) were included. Eight studies had low risk of bias. Statistical analysis of good-quality RCTs showed a significant beneficial effect of any NSAID in increasing the anesthetic success of IANBs compared with placebo (RR = 1.92; 95% CI, 1.55-2.38). Subgroup analyses showed a similar beneficial effect for ibuprofen, diclofenac, and ketorolac (RR = 1.83 [95% CI, 1.43-2.35], RR = 2.56 [95% CI, 1.46-4.50], and RR = 2.07 [95% CI, 1.47-2.90], respectively). Dose-dependent ibuprofen >400 mg/d (RR = 1.85; 95% CI, 1.39-2.45) was shown to be effective; however, ibuprofen ≤400 mg/d showed no association (RR = 1.78; 95% CI, 0.90-3.55). TSA confirmed conclusive evidence for a beneficial effect of NSAIDs for IANB premedication. The Grading of Recommendations, Assessment, Development and Evaluation approach did not reveal any concerns regarding the quality of the results. CONCLUSIONS: Oral premedication with NSAIDs and ibuprofen (>400 mg/d) increased the anesthetic success of IANBs in patients with irreversible pulpitis.
引用
- Nagendrababu V, Pulikkotil SJ, Veettil SK, et al. Effect of Nonsteroidal Anti-inflammatory Drug as an Oral Premedication on the Anesthetic Success of Inferior Alveolar Nerve Block in Treatment of Irreversible Pulpitis: A Systematic Review with Meta-analysis and Trial Sequential Analysis. J Endod. 2018. PMID: 29709297. doi:10.1016/j.joen.2018.02.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。